Pundzienė Birutė, Dobilienė Diana, Čerkauskienė Rimantė, Mitkienė Renata, Medzevičienė Aina, Darškuvienė Elena, Jankauskienė Augustina
Department of Children Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Department of Children Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Medicina (Kaunas). 2015;51(3):146-151. doi: 10.1016/j.medici.2015.06.004. Epub 2015 Jul 5.
The aim of the study was to determine the associations of the acute period course with late-emerging sequelae in children with typical hemolytic uremic syndrome (HUS).
The data of 62 children with typical HUS during the acute phase were retrospectively analyzed by age, sex, duration of anuria/oliguria, method and duration of renal replacement therapy, proteinuria, hypertension, and renal function. The data of 33 children at 10-year follow-up after the onset of the disease were evaluated for changes in hypertension, proteinuria, and renal function.
In the acute phase of the disease (n=62), hypertension was documented in 75.8% of the children; proteinuria, in 85.5%; and renal dysfunction, in 100%. At 10 years after the onset of the disease (n=33), hypertension was documented in 12.1%, 6.1%, and 24.2% at 1-, 5-, and ≥10-year follow-ups, respectively, and more often in children aged <1 year at the onset of the disease. Proteinuria was found in 15.2%, 9.1%, and 33.3% of the patients, respectively. After ≥10 years, hypertension developed for the first time in 6.1% of the patients. Renal injury of varying degrees was seen in 15.2% of the children at the 1-year follow-up, and after ≥10 years the proportion increased to 33.3%.
At 10 years after the acute phase of typical HUS in children, the prevalence of hypertension and proteinuria at 1- and 5-year follow-ups decreased, but after 10 years it started to increase. As much as 6.1% of the children developed hypertension or proteinuria for the first time at 10 years. Hypertension was documented more frequently in children who were younger than <1 year at the onset of the disease. Renal dysfunction after 5 and 10 years remained in more than one-third of cases, and it was observed more often if hypertension was documented at the acute period.
本研究旨在确定典型溶血尿毒综合征(HUS)患儿急性期病程与迟发性后遗症之间的关联。
回顾性分析62例典型HUS患儿急性期的年龄、性别、无尿/少尿持续时间、肾脏替代治疗方法及持续时间、蛋白尿、高血压和肾功能等数据。对33例患儿发病后10年随访时的高血压、蛋白尿和肾功能变化进行评估。
在疾病急性期(n = 62),75.8%的患儿出现高血压;85.5%出现蛋白尿;100%出现肾功能障碍。发病后10年(n = 33),在1年、5年和≥10年随访时,高血压的记录分别为12.1%、6.1%和24.2%,且在发病时年龄<1岁的患儿中更为常见。蛋白尿分别在15.2%、9.1%和33.3%的患者中被发现。≥10年后,6.1%的患者首次出现高血压。1年随访时,15.2%的患儿出现不同程度的肾损伤,≥10年后这一比例增至33.3%。
儿童典型HUS急性期后10年,1年和5年随访时高血压和蛋白尿的患病率下降,但10年后开始上升。6.1%的儿童在10岁时首次出现高血压或蛋白尿。发病时年龄<1岁的患儿高血压更为常见。5年和10年后,超过三分之一的病例仍存在肾功能障碍,急性期出现高血压时更常观察到这种情况。